Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response
NCT ID: NCT04193020
Last Updated: 2021-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2020-01-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each patient is treated in accordance to the best of medical knowledge and guidelines for each disease.
This prospective cohort study will enroll uveitic patients to the steroid only group (SG), combined (steroid and adjuvant drug) group (CG) or bilogic therapy group (BTG).
At baseline, patient data are recorded using patient-reported outcome measures and clinical assessments (ophthalomology) on disease activity (clinical scales), quality of life, and lifestyle together with registry data on comorbidity and medication. During follow-up evaluation of a successful treatment outcome response will be based on clinical scales and most frequently used primary endpoints; the major outcome of the analyses will be to detect differences in treatment outcome between patients in different treatment group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differences in Genes and Proteins in Active and Controlled Uveitis
NCT00357266
Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization.
NCT05659940
Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.
NCT01903642
Chronic Inflammation and Exercise Responsiveness
NCT02732509
Stress, Inflammation and Immune Response Pilot Study- Aim 3
NCT04857151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
steroid only group (SG)
Surveillance card
Surveillance card and additional examination to find novel markers and better assess the existing ones
combined (steroid and adjuvant drug) group (CG)
Surveillance card
Surveillance card and additional examination to find novel markers and better assess the existing ones
bilogic therapy group (BTG)
Surveillance card
Surveillance card and additional examination to find novel markers and better assess the existing ones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surveillance card
Surveillance card and additional examination to find novel markers and better assess the existing ones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* recurrence of the diagnosed previously uni or bilateral uveitis
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wrocław University of Science and Technology
OTHER
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joanna Przeździecka-Dołyk
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marta Misiuk-Hojło, Professor
Role: STUDY_CHAIR
Medical University of Wrocław
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology
Wroclaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joanna Przeździecka-Dołyk, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST-859
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.